Biosceptre International Ltd (Biosceptre) is a biotechnology company that develops antibody technologies for applications in the diagnosis and treatment of cancer. The company develops imaging technologies to detect and monitor cancer. Its diagnostic products are used for the detection of various cancer tissues, and treatment of various cancers in humans and other mammals. Biosceptre offers clinical product development programs such as polyclonal antibody, domain antibodies and topical formulation to treat basal cell carcinoma and other skin cancers. The company also develops diagnostics and a line of veterinary therapeutic products. It has operations in the UK, Australia, and the US. Biosceptre is headquartered in Cambridge, the UK.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
Scope:
Reasons to Buy:
Note: Some sections may be missing if data is unavailable for the company
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
Scope:
- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company Biosceptre International Ltd
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note: Some sections may be missing if data is unavailable for the company
Table of Contents
Biosceptre International Ltd Company OverviewBiosceptre International Ltd Company Snapshot
Biosceptre International Ltd Pipeline Products and Ongoing Clinical Trials Overview
Biosceptre International Ltd – Pipeline Analysis Overview
Biosceptre International Ltd - Key Facts
Biosceptre International Ltd - Major Products and Services
Biosceptre International Ltd Pipeline Products by Development Stage
Biosceptre International Ltd Pipeline Products Overview
BPM09 - IHC Antibody Diagnostic Assay
BPM09 - IHC Antibody Diagnostic Assay Product Overview
Breast Cancer IHC Diagnostic Test
Breast Cancer IHC Diagnostic Test Product Overview
Fluid Based Diagnostic Test - Cancer
Fluid Based Diagnostic Test - Cancer Product Overview
mAb based IHC Diagnostic Test
mAb based IHC Diagnostic Test Product Overview
Prostate Cancer IHC Diagnostic Test
Prostate Cancer IHC Diagnostic Test Product Overview
Skin Cancer IHC Diagnostic Test
Skin Cancer IHC Diagnostic Test Product Overview
Biosceptre International Ltd - Key Competitors
Biosceptre International Ltd - Key Employees
Biosceptre International Ltd - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Recent Developments
Biosceptre International Ltd, Recent Developments
Feb 21, 2014: Biosceptre moves corporate headquarters to the UK from Australia
Appendix
Methodology
About the Publisher
Contact
Disclaimer
List of Tables
Biosceptre International Ltd Pipeline Products and Ongoing Clinical Trials Overview
Biosceptre International Ltd Pipeline Products by Equipment Type
Biosceptre International Ltd Pipeline Products by Indication
Biosceptre International Ltd, Key Facts
Biosceptre International Ltd, Major Products and Services
Biosceptre International Ltd Number of Pipeline Products by Development Stage
Biosceptre International Ltd Pipeline Products Summary by Development Stage
BPM09 - IHC Antibody Diagnostic Assay - Product Status
BPM09 - IHC Antibody Diagnostic Assay - Product Description
Breast Cancer IHC Diagnostic Test - Product Status
Breast Cancer IHC Diagnostic Test - Product Description
Fluid Based Diagnostic Test - Cancer - Product Status
Fluid Based Diagnostic Test - Cancer - Product Description
mAb based IHC Diagnostic Test - Product Status
mAb based IHC Diagnostic Test - Product Description
Prostate Cancer IHC Diagnostic Test - Product Status
Prostate Cancer IHC Diagnostic Test - Product Description
Skin Cancer IHC Diagnostic Test - Product Status
Skin Cancer IHC Diagnostic Test - Product Description
Biosceptre International Ltd, Key Employees
Biosceptre International Ltd, Subsidiaries
Glossary
List of Figures
Biosceptre International Ltd Pipeline Products by Equipment Type
Biosceptre International Ltd Pipeline Products by Development Stage
Samples
LOADING...
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Oxford BioTherapeutics Ltd
- Mina Therapeutics Ltd
- Tyg Oncology Ltd
